Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Healthy donor-derived FMT capsule is an investigational microbiome-based therapy developed by Shanghai Zhongshan Hospital. It consists of fecal microbiota harvested from healthy donors, processed and encapsulated for oral administration. The therapy is primarily being evaluated for the treatment of chronic constipation in patients with Parkinson's disease. By introducing a diverse and healthy microbial community into the recipient's gut, the treatment aims to restore microbial homeostasis, improve gastrointestinal motility, and potentially influence the gut-brain axis to alleviate both digestive and neurological symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Healthy donor-derived FMT capsule (Shanghai Zhongshan Hospital).